Sectors
BNTX
BioNTech SE
101.61
2 x 73.44
2 x 130.13
bid
ask
-
0.47
0.46%
2 @ 07:09 PM
102.00 +0.39 (0.38%)
| Ytd | 6.73% | |
| 1y | 1.61% |
100.84
day range
103.00
79.52
52 week range
124.00
| Open | 102.01 | Prev Close | 102.08 | Low | 100.84 | High | 103.00 | Mkt Cap | 25.52B |
| Vol | 1.09M | Avg Vol | 1.21M | EPS | -7.82 | P/E | N/A | Forward P/E | -18.04 |
| Beta | 1.28 | Short Ratio | 2.72 | Inst. Own | 20.37% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | 06-02 | Earning | 11-03 | 50-d Avg | 95.27 | 200-d Avg | 97.75 | 1yr Est | 120.47 |
| Income Statement | |||
| Total Revenue | 105.60M | ||
| Revenues (USD) | 120.00M | ||
| Cost of Revenue | 97.00M | ||
| Gross Profit | 8.60M | ||
| Operating Expenses | 956.70M | ||
| Research and Development Expense | 551.00M | ||
| Selling, General and Administrative Expense | 197.80M | ||
| Operating Income | -948.10M | ||
| Interest Expense | 7.90M | ||
| Income Tax Expense | -37.90M | ||
| Net Income | -820.80M | ||
| Net Income Common Stock | -820.80M | ||
| Net Income Common Stock (USD) | -932.73M | ||
| Consolidated Income | -820.80M | ||
| Earnings per Basic Share | -3.24 | ||
| Earnings per Basic Share (USD) | -3.68 | ||
| Earnings per Diluted Share | -3.24 | ||
| Earning Before Interest & Taxes (EBIT) | -850.80M | ||
| Earning Before Interest & Taxes (USD) | -966.82M | ||
| Weighted Average Shares | 252.88M | ||
| Balance Sheet | |||
| Cash and Equivalents | 9.74B | ||
| Cash and Equivalents (USD) | 11.07B | ||
| Investments | 7.23B | ||
| Investments Current | 5.21B | ||
| Investments Non-Current | 2.02B | ||
| Trade and Non-Trade Receivables | 163.90M | ||
| Current Assets | 15.30B | ||
| Property, Plant & Equipment Net | 1.22B | ||
| Total Assets | 20.34B | ||
| Debt Current | 135.50M | ||
| Total Debt | 484.40M | ||
| Current Liabilities | 1.95B | ||
| Debt Non-Current | 348.90M | ||
| Total Liabilities | 2.59B | ||
| Accumulated Retained Earnings (Deficit) | 16.61B | ||
| Shareholders Equity | 17.76B | ||
| Shareholders Equity (USD) | 20.18B | ||
| Assets Non-Current | 5.05B | ||
| Total Debt (USD) | 550.45M | ||
| Deferred Revenue | 830.10M | ||
| Goodwill and Intangible Assets | 1.79B | ||
| Inventory | 100.60M | ||
| Liabilities Non-Current | 635.90M | ||
| Trade and Non-Trade Payables | 646.70M | ||
| Tax Assets | 86.60M | ||
| Tax Liabilities | 54.50M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 266.10M | ||
| Net Cash Flow from Financing | -108.50M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -198.10M | ||
| Capital Expenditure | -51.20M | ||
| Issuance (Purchase) of Equity Shares | -129.20M | ||
| Issuance (Repayment) of Debt Securities | 20.70M | ||
| Net Cash Flow from Investing | -100.10M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -48.10M | ||
| Net Cash Flow from Operations | 10.50M | ||
| Effect of Exchange Rate Changes on Cash | -3.30M | ||
| Share Based Compensation | 7.90M | ||